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Abstract 
 
The majority of stem cell therapies for corneal repair are based upon the use of progenitor 
cells isolated from corneal tissue, but a growing body of literature suggests a role for 
mesenchymal stromal cells (MSC) isolated from non-corneal tissues. While the mechanism of 
MSC action seems likely to involve their immuno-modulatory properties, claims have 
emerged of MSC transdifferentiation into corneal cells. Substantial differences in 
methodology and experimental outcomes, however, have prompted us to perform a systematic 
review of the published data. Key questions used in our analysis included; the choice of 
markers used to assess corneal cell phenotype, the techniques employed to detect these 
markers, adequate reporting of controls, and tracking of MSC when studied in vivo. Our 
search of the literature revealed 28 papers published since 2006, with half appearing since 
2012. MSC cultures established from bone marrow and adipose tissue have been best studied 
(22 papers). Critically, only 11 studies employed appropriate markers of corneal cell 
phenotype, along with necessary controls. Ten out of these 11 papers, however, contained 
positive evidence of corneal cell marker expression by MSC. The clearest evidence is 
observed with respect to expression of markers for corneal stromal cells by MSC. In 
comparison, the evidence for MSC conversion into either corneal epithelial cells or corneal 
endothelial cells is often inconsistent or inconclusive. Our analysis clarifies this emerging 
body of literature and provides guidance for future studies of MSC differentiation within the 
cornea as well as other tissues. 
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Introduction 
The cornea has been extensively studied as a tissue for stem cell therapies. To date, the 
majority of this research has focused on corneal epithelial progenitor cells located at the 
peripheral edge, or so-called limbus, where the cornea adjoins the sclera [1, 2]. As such, 
cultivated epithelial autografts have become widely used as a standard treatment for repairing 
the ocular surface [3]. Exploring deeper, a number of groups have more recently identified 
corneal/limbal stromal cells with stem cell properties [4-10] and similar studies are also being 
pursued for the innermost cellular layer, the corneal endothelium [11]. Nevertheless, the 
limited availability and sensitive location of corneal tissue present significant challenges for 
autologous corneal stem cell therapies, particularly in cases of bilateral disease. 
Given the limited availability of a patient’s own corneal stem cells, a number of non-
corneal tissues have been investigated as potential sources of epithelial progenitor cells for 
repairing the ocular surface including the oral mucosa [12]. More recently, however, several 
groups have evaluated the potential of mesenchymal stromal cell (MSC) cultures derived 
from tissues of non-corneal origin [13-16]. While much of this research has centered on 
exploiting the immuno-regulatory properties of MSC to encourage corneal healing, claims 
have emerged that mesenchymal cells of non-corneal origin have the capacity to 
transdifferentiate into corneal cells [17-24]. Such a conclusion, if confirmed, would not only 
have important implications for the treatment of corneal diseases, but would have a 
significant impact on our understanding of general MSC biology. Upon initial engagement 
with this literature, however, we have noted substantial differences in experimental design 
and reported outcomes that hamper a clear interpretation of the data. The goal of this concise 
review, therefore, is to systematically evaluate this recent body of literature for evidence of 
non-corneal MSC differentiation into corneal cells.  
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Literature search, terms of reference and method of analysis 
Our study design is based upon published guidelines for the conduct of systematic reviews 
[25]. The initial ‘identification stage’ consisted of searching the PubMed database for studies 
where the terms ‘mesenchymal’ and ‘cornea’ had been used. This search retrieved 296 studies 
published since 1950 (as of July 25th 2014). We subsequently screened these publications for 
studies where cultures of non-transformed mesenchymal stromal cells, established from 
tissues of non-corneal origin, had been examined either in vitro or in vivo for their ability to 
transdifferentiate into corneal cells. Reports of efficacy alone, while interesting, were 
nonetheless excluded from our subsequent analysis. All literature pertaining to these terms of 
reference were included in this systematic review, irrespective of the primary language in 
which the article was published. The evidence presented in each study was evaluated using 
four standard questions. 
 
(1) Have appropriate markers been used to determine transformation to a corneal phenotype? 
(2) By what methods has the expression of these corneal markers been evaluated? 
(3) Have appropriate controls been reported to validate these results? For example, positive 
results obtained by immunostaining should be validated through demonstration of a negative 
control. Likewise, a negative result should be validated through demonstration of a positive 
control. 
(4) In the case of in vivo studies, has the provenance of observed “corneal cells” been traced 
back to the MSC of non-corneal origin by using some form of marker? 
 
Definition of corneal cell phenotype 
Our definition of corneal cell phenotype is based upon the following considerations. To begin, 
the transcription factor paired box 6 (Pax-6) is widely regarded as the canonical marker of eye 
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tissue development and is retained to varying degrees by mature corneal cells. A variety of 
molecules including the transcription factor p63 [26] and cytokeratin 19 [27] have been used 
as markers for corneal epithelial progenitor cells, but neither protein is specific to the cornea. 
Corneal epithelium is therefore defined by expression of the tissue-specific differentiation 
markers cytokeratin 3 (K3) and cytokeratin 12 (K12) [28]. On a technical note, while K3 
expression in corneal epithelial cells can be reliably studied using the monoclonal antibody 
AE5, care must be taken when applying this antibody to detect K3 in other cell types, since it 
is known to cross-react with cytokeratin 2p/76 (K2p/76). Corneal stromal cells (keratocytes) 
are generally defined by expression of CD34, keratocan, lumican, and aldehyde 
dehydrogenase (ALDH), but during wound healing are known to differentiate into wound 
repair fibroblasts (CD34-/CD90+) and myofibroblasts (expressing alpha-smooth muscle actin 
or !-sma) [29]. Nevertheless, since both CD90 and !-sma are expressed by MSC cultures 
[30], they have been excluded as valid markers of corneal differentiation. While specific 
markers for the corneal endothelium are emerging [31], the expression of N-cadherin, zonula 
occludens-1 (ZO-1) and sodium/potassium ATPase are more generally employed to identify 
these cells [32]. Of the three markers used, the presence of sodium/potassium ATPase is 
perhaps most important given the role of this protein in maintaining the pump function of 
corneal endothelial cells required for corneal transparency. 
 
Overview of published literature 
Our literature search identified 28 papers published between January 2006 and June 2014, 
with half of these having been reported since January 2012 [13, 14, 17-20, 22-24, 33-51]. The 
essential details for each study are summarized in the first 5 columns of Table 1. The majority 
of studies have been performed using MSC derived from either bone marrow (13 studies) [13, 
14, 17, 22-24, 38-40, 43, 47, 48, 50] or adipose tissue (9 studies) [19, 33, 35, 42, 44-46, 49, 
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51], with the remainder using MSC extracted from either umbilical cord tissues (4 studies) 
[20, 34, 36, 41] or dental pulp (2 studies) [18, 37]. Most studies have utilized cultures of MSC 
established from human tissues (19 studies) [13, 18-20, 23, 24, 33-39, 41, 42, 45, 46, 49, 51], 
with the balance having been established from rabbits (5 studies) [14, 17, 43, 44, 48], rats (3 
studies) [40, 47, 50] and mice (1 study) [22].  
A large proportion of studies (19 studies) [13, 14, 17, 18, 20, 22, 24, 33-35, 37, 38, 40, 
42-44, 47-49] have involved in vivo experiments, with 11 studies involving administration of 
human MSC into rabbits (6 studies) [18, 33, 35, 37, 38, 42], rats (3 studies) [13, 24, 49] or 
mice (2 studies) [20, 34]. Routes of administration include topical application (10 studies) 
[13, 17, 18, 24, 37, 38, 40, 47-49], typically following alkali burn (9 studies) [13, 14, 17, 18, 
24, 38, 40, 42, 49], with or without carrier/adjunct materials including amniotic membrane (7 
studies) [13, 18, 24, 37, 38, 47, 48] and fibrin (1 study) [17]. Other methods employed include 
direct injection into the cornea (4 studies) [20, 22, 33, 34] or adjacent conjunctiva (1 study) 
[42], stromal implants consisting of MSC cultured within synthetic scaffolds (2 studies) [35, 
44], and intravenous injection (1 study) [14]. Significantly, the fate of administered MSC was 
traced using some form of temporary (DiI or BrdU) or permanent marker (green fluorescent 
protein, human nuclear antigen or sex-linked DNA marker) in only 15 out of 19 studies 
conducted in vivo [13, 14, 17, 18, 20, 22, 33-35, 37, 38, 43, 44, 47, 49]. 
Reports of MSC displaying evidence of corneal phenotype in vitro (15 studies) [17-19, 
23, 24, 36, 39-41, 45-48, 50, 51] have utilized a variety of induction methods including co-
culture in the presence of corneal cells (2 studies) [40, 51], treatment with ocular cell 
conditioned media (3 studies) [17, 41, 46], cultivation in either specialized epithelial cell 
growth media or keratocyte growth media (4 studies) [19, 23, 24, 42], and corneal organ 
culture (2 studies) [39, 41]. Only two studies have utilized specialized enrichment techniques 
such as magnetic assisted cell sorting (MACS for stage-specific embryonic antigen-4 [23]) or 
Corneal differentiation of MSC 
 8 
flow cytometry (side population cells [19]) prior to cultivation (under epithelial or keratocyte 
growth conditions respectively). Surprisingly, 3 studies [18, 45, 48] have claimed evidence of 
corneal phenotype markers being expressed when MSC were apparently maintained in their 
standard growth medium.  
In terms of target tissue, 17 studies [13, 17, 18, 23, 24, 36-40, 42, 45-50] have 
presented data relevant to epithelial differentiation, 9 studies [14, 19, 20, 22, 33-35, 44, 51] 
have examined differentiation into corneal stromal cells (keratocytes), and 2 studies [41, 43] 
have examined the potential of MSC to produce corneal endothelium.  
The last five columns of Table 1 present the results from our analysis of published 
data using the standard set of four questions. For convenience, the highlights from this 
analysis are discussed below according to MSC tissue of origin and are summarized in Table 
2. 
 
Corneal differentiation of bone marrow-derived MSC (BM-MSC)  
Of the 13 studies involving BM-MSC, only 7 papers contain data that according to our 
analysis has been validated through use of appropriate markers and controls [13, 17, 22-24, 
38, 50]. Six of these papers have addressed conversion of MSC into corneal epithelium with 
the remaining paper exploring keratocyte differentiation in vivo.  
While one study found negative evidence of human BM-MSC differentiation into 
corneal epithelium when applied to the ocular surface of rats (validated by positive control) 
[13], the combined data from an additional 5 studies involving cells from rabbits [17], rats 
[50] or human subjects [23, 24, 38] provides partial evidence of K3 and/or K12 expression 
under either in vitro or in vivo conditions. Nevertheless, the level of K3 or K12 expression 
observed in these papers is consistently less than that for corneal epithelium and often limited 
to a subset of cells. At the very least, therefore, it appears that BM-MSC have some ability to 
Corneal differentiation of MSC 
 9 
produce low levels of cornea-specific keratins, but it remains unclear as to whether this level 
of expression represents true conversion to a functional corneal epithelial cell phenotype. 
The single paper containing evidence of BM-MSC differentiation into keratocytes in 
vivo is convincing given that the cells were implanted into kera -/- null mutant mice [22]. 
Thus, the subsequent observation of keratocan expression in conjunction with DiI labeled 
cells is justifiably explained by conversion of BM-MSC into keratocytes. Nevertheless, it is 
unclear as to what percentage of administered MSC adopted a keratocyte phenotype. 
Only one study has examined the potential of BM-MSC to transdifferentiate into 
corneal endothelial cells [43]. In this study (published in Chinese language), the authors 
report improvements in corneal clarity and thickness when autologous BM-MSC cultured on 
gelatin membranes are adhered to the posterior surface of corneal buttons implanted into 
rabbits. While these results are encouraging in terms of efficacy, the phenotype of implanted 
cells was only examined using a combination of morphological techniques (live confocal 
imaging and scanning electron microscopy). 
 
Corneal differentiation of MSC-derived from adipose tissue (A-MSC)  
Reports of A-MSC conversion into corneal cells are, according to our criteria, also often 
lacking appropriate markers of cell phenotype and necessary controls (5 out of 9 studies). 
Moreover, the results for a further 3 studies are clouded by either inconsistent or unclear data.  
The case for A-MSC differentiation into corneal epithelial cells is particularly weak. 
Only one in vitro study contains validated data in support of this hypothesis [45] and even in 
this paper there are inconsistencies with respect to the measurement of corneal phenotype 
markers by immunocytochemistry, Western blotting and RT-PCR. In short, while “moderate” 
levels of K3 were reported using immunocytochemistry and Western blotting, the mRNA 
transcripts required for producing this protein were not detected by RT-PCR. Nevertheless, 
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weak expression was reported by RT-PCR for K12 and this was confirmed by sequencing. 
These results were apparently obtained for A-MSC grown in their standard expansion 
medium. Further studies are therefore required to clarify whether A-MSC have potential to 
produce corneal epithelium and ideally this research should be extended to in vivo models as 
well. 
One study has reported elevated levels of both ALDH and keratocan by flow 
cytometry when A-MSC are co-cultured in the presence of corneal stromal cells, but no 
change in transcript numbers for either protein was detected by RT-qPCR [51]. Likewise, 
while a faint band for human keratocan was detected by Western blot after injecting human 
A-MSC into rabbit corneas, background fluorescence hampers a clear interpretation of the 
images reported to show DiI-labeled cells [33]. Nevertheless, a separate study utilizing the 
side population fraction of human A-MSC isolated by flow cytometry, provides good 
evidence of keratocan and ALDH expression using a combination of techniques [19]. It 
therefore seems quite plausible that A-MSC could be used as a source of keratocytes, but this 
case could also be strengthened by more data including studies in vivo. 
 
Corneal differentiation of MSC-derived from umbilical cord (UC-MSC)  
Research into stem cells derived from umbilical cord is a complex topic as mesenchymal cells 
with progenitor cell properties have been isolated from the cord blood as well as the 
surrounding primitive connective tissue. In addition, epithelial progenitor cells have been 
isolated from umbilical cords. All three sources of progenitor cells have been examined as 
tools for corneal reconstruction. For the purpose of this systematic review, however, we have 
focused on the evidence arising from studies using the mesenchymal cell populations 
obtained from umbilical cord tissues.  
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Out of the 4 studies identified by our literature search, only one report contains 
evidence that has been validated through use of appropriate markers and controls [20]. In this 
study, human UC-MSC loaded with DiI were injected into dysfunctional corneas of lum -/- 
and kera -/- null mutant mice. The labeled cells subsequently became integrated within the 
host tissue and adopted a morphology similar to that expected for keratocytes. Evidence of 
transdifferentiation was provided by co-localization of the DiI tracker dye with observed 
patterns of immunohistochemistry for keratocan, lumican and CD34, with lumican and 
keratocan expression being confirmed by Western blotting. A subsequent study by this 
research group using a mouse model of lysosomal enzyme dysfunction has produced similar 
results, but specific markers of corneal phenotype were not used on this occasion [34].  
One additional paper requires mention since it is one of the few studies to have 
evaluated the potential of MSC derived from any non-corneal tissue to adopt a corneal 
endothelial cell phenotype [41]. In this study, a sub-culture of UC-MSC was examined for 
evidence of ZO-1 and N-cadherin expression prior to and following treatment with lens 
epithelium conditioned medium. GFP-labeled cells were also examined for these same 
markers following two weeks cultivation upon the wounded posterior surface of donor human 
corneas. While both ZO-1 and N-cadherin were detected in un-treated cultures (validated by 
controls) these proteins reportedly became more distributed to cell boundaries (both in 
standard and organ cultures) in the presence of conditioned medium. Moreover, the results 
from a microarray analysis of 250 genes indicated a shift towards a phenotype closer to that 
of corneal endothelial cells when treated with conditioned medium. Interestingly, the 
integration of labeled UC-MSC with the organ cultured endothelial cells was best encouraged 
by attachment to the surface of damaged cells rather than by contact with exposed areas of 
Descemet’s membrane. These findings support the theory of ‘licensing’ whereby MSC are 
activated or primed by local signals such as those produced by damaged and necrotic cells. 
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While these results are somewhat encouraging, the presence of ZO-1 and N-cadherin in 
untreated cultures raises questions about the degree of transdifferentiation. When taken 
together with the functional data observed using BM-MSC [43], however, these finding 
suggest that MSC might at very least provide a partial surrogate for corneal endothelial cells 
in the event that transdifferentiation does not occur. 
 
Corneal differentiation of MSC-derived from dental pulp (DP-MSC) 
While only two studies by one group have explored the potential of DP-MSC as a source of 
corneal tissue [18, 37], both papers contain validated evidence of cornea-specific keratin 
expression. In the first study [18], while only traces of K3/K12 were detected in cultures of 
human DP-MSC by immunostaining (with transcripts for K12 detected by RT-PCR), co-
expression of K3 and human nuclear antigen was detected by immunostaining following 
application to the wounded ocular surface of rabbits. These in vivo findings were essentially 
confirmed a year later in the group’s second study [37]. 
 
Conclusions and recommendations 
While there is evidence that MSC derived from tissues of non-corneal origin have some 
ability to produce proteins associated with corneal phenotype, only 10 out of the 28 papers 
that we analysed presented validated data in support of this hypothesis (summarized in Table 
2). The strongest evidence exists with regard to expression of markers associated with corneal 
stromal cells (keratocytes), largely owing to the use of null mutant animal models and 
multiple sources of MSC having been tested with positive results. Although a greater number 
of studies have observed expression of markers associated with corneal epithelium, there are 
often significant gaps in the evidence provided, with many studies relying solely on 
immunohistochemistry data and several reports indicating that only a subpopulation of MSC 
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may be involved. Despite some interesting preliminary data, convincing evidence of MSC 
conversion into corneal endothelial cells has yet to be published.  
On weight of evidence, we must therefore conclude that there is indeed value in 
pursuing the use of MSC from tissues of non-corneal origin as a potential source of corneal 
cells, and especially in the case of stromal tissue reconstruction. Nevertheless, the evidence 
for MSC differentiation into either corneal epithelial cells or corneal endothelial cells is 
relatively less clear. With regard to future studies, a number of key recommendations can be 
made.  
1. First and foremost, specific markers of corneal phenotype should be used and 
ideally the expression of Pax-6, in conjunction with its recently identified regulator 
Wnt7A [52]), should also be examined as the canonical marker of ocular tissue 
development. In doing so, these studies will be consistent with the best evidence-based 
strategies being used for studying directed differentiation of induced pluripotent stem 
(iPS) cells. 
2. Given the technical limitations of some antibodies used for detection of corneal cell 
phenotype (e.g. AE5 antibody to K3/K2p/76), the expression of corneal specific 
markers should always be confirmed at the transcriptional level. Moreover, reporting 
of experimental controls should be mandatory.  
Failure to comply with either of these first two recommendations, risks production of data that 
would be unlikely to pass quality control measures required under good manufacturing 
practice (GMP) for clinical applications. 
3. In the case of studies being conducted in vivo, it is essential that the provenance of 
observed “corneal cells” be traced back to the MSC administered to the animal. 
4. Finally, while the majority of positive evidence has been obtained for MSC cultures 
established from bone marrow, this trend no doubt arises from the wider availability of 
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this resource and thus should not be taken to indicate an optimal MSC type for corneal 
reconstruction. Indeed, it could well be argued that MSC isolated from craniofacial 
tissues provide a more appropriate source, given their shared embryonic origin with 
corneal stromal cells and corneal endothelial cells (cranial neural crest). 
 
In drawing our conclusions, we must stress that the findings of this systematic review 
in no-way detract from the broader potential use of MSC as a therapeutic agent for corneal 
repair through their proven abilities to modulate immune responses. Indeed, in the course of 
reviewing the 28 papers we noted several claims of improvements in corneal structure and/or 
function following administration of MSC [18, 20, 34, 42, 47, 49]. Moreover, there have been 
case reports of clinical efficacy outside the scope of our systematic review [53]. The question 
of whether or not transdifferentiation is necessary for a therapeutic effect is therefore perhaps 
academic, but we trust that our analysis provides some much needed clarity with respect to 
the mechanism of MSC action within the cornea. 
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Table 1. Results of systematic review for prior studies of non-corneal MSC conversion into corneal cells. 
!
Tissue of 
MSC 
origin 
 
Study Species 
of 
MSC 
origin 
Study 
design 
Host 
species 
Correct 
markers 
used 
Adequate 
controls 
used 
Origin of 
cells 
tracked 
 
Our conclusions 
 
Result 
[38] Human In vivo Rabbit Yes Yes Yes 
(Human 
antigen) 
Transplanted cells formed epithelial-like 
structure on ocular surface. Cells were 
immunoreactive for K12 and human 
nuclear antigen.  
 
!Ep 
[14] Rabbit In vivo Rabbit No 
("-sma) 
- Yes  
(DiI) 
Evidence of MSC survival and 
conversion into myofibroblasts. 
Inc. S 
[13] Human In vivo Rat Yes Yes Yes  
(Human 
antigen) 
Transplanted cells formed epithelial-like 
structure on ocular surface, but staining 
for cytokeratin was negative. 
 
XEp 
 
Bone 
marrow 
[43] Rabbit In vivo Rabbit 
Auto 
No 
(Morph.) 
No Yes 
(BrdU) 
Some evidence of ability to substitute for 
corneal endothelial cell function, but poor 
 
?En 
! #!
 evidence of transdifferentiation. 
[17] Rabbit In vivo 
 
In vitro 
Rabbit 
 
- 
Yes 
 
Yes 
No 
 
Yes 
Yes 
(BrdU) 
- 
Evidence of MSC survival in vivo. 
 
10% of cells express K3 in vitro. 
 
!Ep 
[40] Rat In vivo 
In vitro  
Rat Yes 
Yes 
Yes 
No 
No 
- 
Poor evidence without tracking of cells. 
Poor evidence without control data. 
 
Inc. Ep 
[39] Human Organ 
culture 
Pig Yes Yes No Cultures grown on denuded pig corneas 
displayed positive staining for K12 but 
origin of cells is unclear. 
 
Inc. Ep 
[48] Rabbit In vivo 
In vitro 
Rabbit 
- 
Yes 
Yes 
No 
No 
No 
- 
Poor evidence without control/tracking. 
Cultured MSC reported to express 
K3/K12, but data not shown. 
 
Inc. Ep 
[50] Rat In vitro - Yes Yes - K3 expression (IHC, no controls) 
supported by RT-PCR and WB. 
 
!Ep 
 
[22] Mouse In vivo Mouse 
Kera -/- 
Yes Yes Yes  
(DiI) 
Evidence of conversion into keratocytes.  
!S 
! $!
[24] Human In vivo 
In vitro 
Rat 
- 
Yes 
Yes 
Yes 
Yes 
No 
- 
Poor evidence without tracking. 
Evidence of K3 in vitro. 
 
!Ep 
[23] Human 
 
In vitro - Yes Yes - K3 expression confirmed by ICC and 
RT-qPCR, but less than for control tissue. 
 
!Ep 
 
[47] Rat 
Male 
 
 
In vivo 
 
In vitro 
Rat 
Female 
- 
No  
(K19) 
No 
(K19) 
No 
 
No 
Yes (male 
DNA) 
- 
Traces of male DNA detected in vivo, but 
K19 not specific for corneal cells. 
 
Inc. Ep 
[33] Human In vivo Rabbit Yes Yes Yes  
(DiI) 
IHC data Inconclusive due to high 
background. Faint band for human 
keratocan detected by RT-PCR. 
 
?S 
[19] Human In vitro - Yes Yes - Keratocan expression confirmed by WB, 
RT-PCR and RT-qPCR. 
!S 
Adipose 
tissue 
[45] Human In vitro - Yes Yes - Inconsistencies are reported with respect 
to K3 expression when measured by ICC, 
WB, RT-PCR and RT-qPCR. 
 
?Ep 
! %!
[35] Human In vivo Rabbit Yes No Yes  
(DiI) 
Poor evidence without control data.  
Inc. S 
[42] Human In vivo Rabbit No 
(H&E) 
- No Poor evidence without appropriate 
markers and tracking of cells. 
 
Inc. Ep 
[46] Human 
 
 
In vitro - Yes Yes - Inconclusive owing to expression of 
K3/K12 throughout all cultures tested 
including limbal fibroblasts. 
 
Inc. Ep 
[44] Rabbit 
 
 
In vivo Rabbit 
Auto 
Yes No Yes  
(GFP) 
Co-localization of GFP with keratocan 
and ALDH difficult to interpret without 
adequate controls. 
 
Inc. S 
[49] Human 
 
 
In vivo Rat No 
(H&E) 
- Yes 
(CFSE) 
Traces of label detected, but data 
Inconclusive without exploring 
expression of cell phenotype. 
 
Inc. Ep 
 
[51] Human In vitro - Yes Yes - Inconsistencies are reported with respect 
to measurement of ALDH and keratocan 
by RT-qPCR and flow cytometry. 
?S 
! &!
[20] Human In vivo Mice 
Lum -/- 
Kera -/- 
Yes Yes Yes  
(DiI) 
Good evidence provided of cells 
differentiating into functioning 
keratocytes. 
 
!S 
[34] Human In vivo Mice 
 
No 
(F-actin) 
No Yes  
(DiI) 
Evidence of cell survival and appropriate 
morphology. No markers of phenotype 
assessed. 
 
Inc. S 
 
Umbilical 
cord 
[36] Human In vitro - Yes No - Poor evidence without control data. Inc. Ep 
Umbilical 
cord 
blood 
[41] Human Organ 
culture 
Human Yes Yes Yes  
(GFP) 
A shift observed towards a phenotype 
similar to corneal endothelial cells. 
 
?En 
[18] Human In vivo 
 
 
In vitro 
Rabbit Yes 
 
 
Yes 
Yes 
 
 
Yes 
Yes 
(Human 
antigen) 
- 
Co-expression of K3 and human antigen 
 
 
Traces of K3/K12 in a few cells. 
!Ep Dental 
pulp 
[37] Human In vivo Rabbit Yes Yes Yes 
(Human 
Co-expression of K3 and human antigen !Ep 
! '!
 antigen) 
!
Abbreviations. Host species: Kera -/- = keratocan null mutant mice, Auto = autologous transplant, Lum -/- = lumican null mutant mice. Markers 
of cell phenotype: ALDH = aldehyde dehydrogenase, "-sma = alpha smooth muscle actin, F-actin = filamentous actin, H&E = hematoxylin and 
eosin staining, K3 = cytokeratin 3, K12 = cytokeratin 12, K19 = cytokeratin 19, Morph. = morphology assessed. Cell tracker reagents: CFSE = 
Carboxyfluorescein succinimidyl ester, BrdU = bromo deoxyuridine, DiI = a fluorescent lipophilic dialkylcarbocyanine dye, GFP = green 
fluorescent protein. Conclusions comments: MSC = mesenchymal stromal cells of non-corneal origin, IHC = immunohistochemistry, RT-qPCR 
= quantitative (real time) reverse transcriptase polymerase chain reaction, RT-PCR = reverse transcriptase polymerase chain reaction, WB = 
Western blotting, ICC = immunocytochemistry. Result comments: Inc. = Inconclusive evidence, XEp = negative evidence for epithelial 
differentiation, !Ep = positive evidence for epithelial differentiation, !S = positive evidence for stromal cell (keratocyte) differentiation, ?S = 
partial evidence of stromal differentiation, ?Ep = partial evidence of epithelial differentiation, ?En = partial evidence of differentiation into 
corneal endothelial cells. 
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Table 2. Summary of validated evidence for MSC conversion to corneal phenotype. 
 
 
 BM-MSC A-MSC UC-MSC DP-MSC 
Corneal epithelium X !!!!!* ?   !!  
Corneal stromal cells !  !?? !   
Corneal endothelium ?  ?   
 
Source of MSC: BM-MSC = derived from bone marrow, A-MSC = derived from adipose tissue, U-MSC = derived from umbilical cord, DP-
MSC = derived from dental pulp. 
Scoring: X = study reporting validated negative evidence, !  = study reporting validated positive evidence, ? = partial evidence of conversion. 
*Note: In the majority of these studies, the levels of expression reported for corneal specific keratins (K3/K12) are substantially lower than that 
seen in corneal epithelial cells (positive control) and immunoreactivity is often limited to a small subset of cells. 
